Iovance Biotherapeutics, Inc. (LON:0JDK)
London · Delayed Price · Currency is GBP · Price in USD 2.259
-0.022 (-0.96%)
At close: Dec 12, 2025
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of 653.88 million as of December 12, 2025. Its market cap has decreased by -70.48% in one year.
Market Cap
653.88M
Enterprise Value
467.97M
Revenue
186.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.26
Market Cap Chart
Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 62.39M to 653.88M, an increase of 948.09%. That is a compound annual growth rate of 16.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 653.88M | -63.70% |
| Dec 31, 2024 | 1.80B | 10.29% |
| Dec 29, 2023 | 1.63B | 95.13% |
| Dec 30, 2022 | 837.09M | -62.16% |
| Dec 31, 2021 | 2.21B | -55.63% |
| Dec 31, 2020 | 4.99B | 89.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.48B |
| GSK plc | 73.26B |
| Haleon | 31.93B |
| Smith & Nephew | 10.31B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.36B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.67B |